Stock listing
NASDAQ:DBTX Decibel Therapeutics Inc Stock
Follow Decibel Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:DBTX
$4.91 USD
Close on Oct 4, 2023 · No longer trades
- Lowest – highest close
- $1.85 – $19.90 USDSince Feb 12, 2021 · lowest May 9, 2022 · highest Feb 22, 2021
Delisted NASDAQ:DBTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:DBTX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Decibel Therapeutics Inc on 6ix
- Decks
- 1 deck · latest Jan 9, 2023
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 41st Annual Healthcare Meeting January 2023 | Conference | 28 slides | Jan 9, 2023 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Neil Exter Other companies: Maze Therapeutics, Inc. (Director · Since at least Jan 30, 2025); Pliant Therapeutics, Inc. (Director · Jun 2, 2020 – Jun 16, 2022 · Past); Revolution Medicines, Inc. (Director · Feb 12, 2020 – Jun 16, 2022 · Past); Rhythm Pharmaceuticals, Inc. (Director · Oct 4, 2017 – Jun 6, 2018 · Past); CytomX Therapeutics, Inc. (Director · Oct 7, 2015 – Jun 20, 2017 · Past) | Director · Feb 11, 2021 – Jun 17, 2022 · Past |
| Kevin F. McLaughlin Other companies: Invivyd, Inc. (Director · Since at least May 21, 2024); Vericel Corporation (Director · Since at least Jan 6, 2015); Acceleron Pharma Inc (SVP, CFO and Treasurer · Jul 7, 2015 – Nov 19, 2021 · Past) | Director · Oct 10, 2022 – Sep 25, 2023 · Past |
| William H. Carson Other companies: Annexon, Inc. (BOARD MEMBER · Since at least Feb 5, 2021); Prevail Therapeutics Inc (Director · Sep 9, 2020 – Jan 22, 2021 · Past) | Director · Jun 2, 2021 – Sep 25, 2023 · Past |
| Cynthia W Hu Other companies: Definium Therapeutics, Inc. (Chief Legal Officer&Secretary · Jan 1, 2022 – Mar 24, 2022 · Past) | General Counsel · Aug 16, 2021 – Aug 16, 2021 · Past |
| James B Murphy Other companies: Mustang Bio, Inc. (Interim CFO · Jan 19, 2024 – Jan 19, 2024 · Past) | See Remarks · Oct 7, 2022 – Oct 7, 2022 · Past |
| Matthew C Kapusta Other companies: uniQure N.V. (CEO, Managing Director, Director · Since at least Jan 1, 2017) | Director · Mar 19, 2023 – Sep 25, 2023 · Past |
| John Jui-Jen Lee | Chief Development Officer · Feb 11, 2021 – Sep 25, 2023 · Past |
Log in to ask 6ix AI your own questions about Decibel Therapeutics Inc.